PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryDec 19, 2016	Integra LifeSciences to Present at the 35th Annual J.P. Morgan Healthcare Conference in January 2017 PLAINSBORO, N.J., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conference in January: At 2:30PM PT on Wednesday, January 11, 2017, Mr. Peter Arduini, President and CEO will present at the 35 th Annual	View HTML Integra LifeSciences to Present at the 35th Annual J.P. Morgan Healthcare Conference in January 2017 13.4 KB
Toggle SummaryDec 22, 2016	Integra LifeSciences Announces Approval of Two-for-One Stock Split PLAINSBORO, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that its stockholders approved a two-for-one stock split and an increase from 60 million to 240 million authorized shares of the Company's common stock at a special meeting of	View HTML Integra LifeSciences Announces Approval of Two-for-One Stock Split 11.1 KB
Toggle SummaryJan 10, 2017	Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook Expands regenerative technology capabilities and accelerates advanced wound care strategy with the addition of amniotic tissue-based products Leverages existing sales channel with the addition of a complementary line of advanced wound care products Expects 7% to 8.5% organic revenue growth in 2017	View HTML Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook 24 KB
Toggle SummaryJan 25, 2017	Integra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc. PLAINSBORO, N.J., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation ("Integra") (NASDAQ:IART), a global leader in medical technology, announced today that its wholly-owned subsidiary, Integra Derma, Inc. ("Offeror"), is commencing a cash tender offer to purchase all	View HTML Integra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc. 14.4 KB
Toggle SummaryJan 26, 2017	Integra LifeSciences to Host Its Fourth Quarter 2016 Earnings Results Conference Call on February 23, 2017 PLAINSBORO, N.J., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its fourth quarter 2016 financial results on Thursday, February 23, 2017. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Fourth Quarter 2016 Earnings Results Conference Call on February 23, 2017 10.4 KB
Toggle SummaryFeb 15, 2017	Integra LifeSciences Plans to Acquire the Codman Neurosurgery Business from Johnson & Johnson for $1.045 Billion in Cash Enhances global position in neurosurgery by adding a complementary product portfolio and the world-recognized Codman brand Builds relevant scale, accelerates international growth and expands the neurosurgery sales channel Accelerates Integra's strategy to achieve aspirational targets of $2 billion	View HTML Integra LifeSciences Plans to Acquire the Codman Neurosurgery Business from Johnson & Johnson for $1.045 Billion in Cash 25.2 KB
Toggle SummaryFeb 23, 2017	Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 2016 Results and 2017 Guidance in line with January 10, 2017 Preliminary Announcement	View HTML Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 69.7 KB
Toggle SummaryFeb 23, 2017	Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc. PLAINSBORO, N.J., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation ("Integra") (NASDAQ:IART), a global leader in medical technology, announced today that its tender offer by its wholly-owned subsidiary, Integra Derma, Inc. ("Offeror"), to purchase all outstanding common	View HTML Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc. 12.7 KB
Toggle SummaryFeb 28, 2017	Integra LifeSciences to Present at the Barclays Global Healthcare Conference and Oppenheimer's 27th Annual Healthcare Conference in March 2017 PLAINSBORO, N.J., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in March: At 9:00AM ET on Tuesday, March 14, 2017, Mr. Glenn Coleman, Chief Financial Officer and Corporate VP of	View HTML Integra LifeSciences to Present at the Barclays Global Healthcare Conference and Oppenheimer's 27th Annual Healthcare Conference in March 2017 13.7 KB
Toggle SummaryMar 15, 2017	Integra LifeSciences Launches Press-Fit Reverse Shoulder for Fracture for the Titan™ Modular Shoulder System PLAINSBORO, N.J., March 15, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, announced the launch of the Titan™ Press-Fit Reverse Shoulder for Fracture. The use of the reverse shoulder to treat humeral fractures has	View HTML Integra LifeSciences Launches Press-Fit Reverse Shoulder for Fracture for the Titan™ Modular Shoulder System 14.3 KB
Toggle SummaryMar 16, 2017	Integra LifeSciences Introduces Next Generation CUSA® Clarity Ultrasonic Tissue Ablation System PLAINSBORO, N.J., March 16, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announces the launch of its new CUSA® Clarity ultrasonic tissue ablation platform designed to deliver an innovative, integrated system for enhanced	View HTML Integra LifeSciences Introduces Next Generation CUSA® Clarity Ultrasonic Tissue Ablation System 13.4 KB
Toggle SummaryMar 28, 2017	Integra LifeSciences Announces Commercial Expansion of the Cadence® Total Ankle System PLAINSBORO, N.J., March 28, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced full commercial availability of its Cadence ® Total Ankle System, a new ankle prosthesis developed in partnership with four	View HTML Integra LifeSciences Announces Commercial Expansion of the Cadence® Total Ankle System 17.1 KB
Toggle SummaryApr 4, 2017	Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan Financing now secured for the planned acquisition of Codman Neurosurgery	View HTML Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan 18.5 KB
Toggle SummaryApr 12, 2017	Integra LifeSciences to Host Its First Quarter 2017 Earnings Results Conference Call on April 26, 2017 PLAINSBORO, N.J., April 12, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release its first quarter 2017 financial results on Wednesday, April 26, 2017. The company has scheduled a conference call for 8:30 AM ET	View HTML Integra LifeSciences to Host Its First Quarter 2017 Earnings Results Conference Call on April 26, 2017 10.3 KB
Toggle SummaryApr 26, 2017	Integra LifeSciences Reports First Quarter 2017 Financial Results Revenue Increased 9.2% to $258.6 million; Organic Revenue Increased 6.4% Reported EPS of $0.08; Adjusted EPS of $0.39 PLAINSBORO, N.J., April 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported its	View HTML Integra LifeSciences Reports First Quarter 2017 Financial Results 64 KB